Evidence map›Paper›PMID 40438681›Full record

ArticleFrontiers in oncology2025

The value of spectral CT quantitative parameters in predicting Ki-67 level in ovarian cancer.

Siwen Pang, Meng Wu, Haijia Yu, Tiantian Ma, Jianhua Liu, Siwen Liu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Siwen PangDepartment of Radiology, Second Affiliated Hospital of Jilin University, Changchun, China.
Meng WuDepartment of Radiology, Second Affiliated Hospital of Jilin University, Changchun, China.
Haijia YuDepartment of Radiology, Second Affiliated Hospital of Jilin University, Changchun, China.
Tiantian MaDepartment of Radiology, Second Affiliated Hospital of Jilin University, Changchun, China.
Jianhua LiuDepartment of Radiology, Second Affiliated Hospital of Jilin University, Changchun, China.
Siwen LiuDepartment of Radiology, Second Affiliated Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The objective of this study is to evaluate the predictive value of quantitative parameters from spectral CT for Ki-67 expression in ovarian cancer (OC). Methods: Spectral CT imaging data from 39 patients with ovarian cancer by pathology, encompassing 52 lesions overall, were collected retrospectively and split into two groups based on immunohistochemical results. Tumor solid components in arterial, venous, and delayed phases can be measured using post-processing software to obtain the quantitative parameters of spectral CT. An independent sample t-test was implemented for evaluating spectral CT parameters between two groups, and a Spearman correlation coefficient was applied among all participants to estimate the relationship between spectral parameters and Ki-67 levels. Moreover, an examination of the receiver operating characteristic (ROC) curve was conducted to assess the diagnostic efficacy of the significantly different parameters between the two groups. Results: The Ki-67 high-level group includes 22 patients and 29 lesions, while the Ki-67 low-level group contains 17 patients and 23 lesions. The A-sIC, A-sZeff, V-IC, D-Zeff, and D-sZeff values in the Ki-67 high-level group were greater than those in the Ki-67 low-level group ( Conclusion: Spectral CT provides multi-parametric imaging data and is useful in predicting Ki-67 expression in ovarian cancer, delivering comprehensive and reliable imaging evidence for the formulation of therapeutic treatment options.

Indexed as

effective atomic numberiodine concentrationKi-67 levelovarian cancerquantitative parametersspectral CTthe slope of the spectral curve

Identifiers

PMID40438681
PMCPMC12116321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.